Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione rapta c

glutathione rapta c The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials Combinative Treatment of the PARP

Combinative Treatment of the PARP Inhibitor Olaparib and Antimetastasis Ruthenium(II)Arene Compound RAPTA T for Triple Negative BRCA1 Wild Type Breast Cancer Cells Structural variations of the ligands in the lead compound RAPTA C. Download Scientific Diagram State of Metal Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases Oncohema Key Anticancer activity of RAPTA EA1 in triple negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib ScienceDirect The development of RAPTA compounds for the treatment of tumors ScienceDirect

SKU: 96606344967 · From lagence-mr.com

4.0
USD29.44 USD73.44

Pay in 4 interest-free payments of $7.36 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Sep 15 - Sep 20

Description

Chris Masterjohn earned his PhD in Nutritional Sciences from the University of Connecticut and gained further expertise as a postdoctoral research associate at the University of Illinois

glutathione rapta c The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials Combinative Treatment of the PARP

Ved, and R.A

glutathione rapta c The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials Combinative Treatment of the PARP

LiXLiLSunYLvFZhangGLiuWet al

glutathione rapta c The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials Combinative Treatment of the PARP

4T1 cells were seeded in 24-well plates or 12-well plates and cultured at 5% CO 2 , 37 C overnight

glutathione rapta c The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials Combinative Treatment of the PARP

10.1016/j.neulet.2022.136821 147 SunX.HuangX.LiangQ.WangN.ZhengX.ZhangQ.et al (2024)

glutathione rapta c The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials Combinative Treatment of the PARP
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products